Henry J Kaplan Selected Research

Wet Macular Degeneration

1/2007	Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody.
3/2003	Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henry J Kaplan Research Topics

Disease

37	Uveitis 12/2021 - 11/2002
19	Inflammation (Inflammations) 10/2021 - 02/2003
11	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2021 - 02/2003
9	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 08/2003
8	Choroidal Neovascularization 01/2015 - 03/2003
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 11/2003
7	Anterior Uveitis 01/2007 - 11/2002
6	Retinal Detachment (Retinal Detachments) 01/2016 - 03/2008
4	Wounds and Injuries (Trauma) 05/2021 - 03/2008
4	Proliferative Vitreoretinopathy 05/2021 - 07/2012
4	Retinal Degeneration 01/2020 - 03/2008
3	Starvation 10/2021 - 04/2016
3	Retinal Diseases 11/2019 - 12/2003
3	Encephalomyelitis (Myeloencephalitis) 08/2004 - 11/2002
2	Blindness (Hysterical Blindness) 05/2021 - 08/2003
2	Neoplasms (Cancer) 01/2017 - 03/2003
2	Epiretinal Membrane (Epiretinal Membranes) 01/2016 - 07/2012
2	Retinal Neovascularization 01/2015 - 03/2003
2	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2013 - 04/2009
2	Macular Edema 02/2013 - 04/2007
2	Wet Macular Degeneration 01/2007 - 03/2003
2	Cataract (Cataracts) 12/2005 - 02/2003
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2021
1	Gliosis 01/2020
1	Ganglion Cysts (Ganglion) 01/2020
1	Corneal Diseases (Corneal Disease) 11/2018
1	Metaplasia 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Body Weight (Weight, Body) 09/2015
1	Vitreous Detachment (Posterior Vitreous Detachment) 07/2012

Drug/Important Bio-Agent (IBA)

20	Retinaldehyde (Retinal)IBA 10/2021 - 02/2003
10	interstitial retinol-binding proteinIBA 12/2021 - 08/2003
10	Peptides (Polypeptides)IBA 12/2021 - 11/2002
7	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 12/2014
6	AntigensIBA 12/2021 - 11/2002
6	CytokinesIBA 12/2021 - 03/2009
6	Complement System Proteins (Complement)IBA 10/2010 - 08/2003
5	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021 - 01/2014
5	Retinal Pigments (Pigments, Visual)IBA 01/2021 - 04/2007
5	Interleukin-17 (Interleukin 17)IBA 09/2011 - 03/2009
4	Rhodopsin (Visual Purple)IBA 10/2021 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 10/2010 - 02/2003
3	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 04/2016
3	Adenosine DeaminaseIBA 01/2021 - 03/2016
3	EnzymesIBA 01/2021 - 04/2005
3	HMGB1 Protein (HMG1)IBA 01/2017 - 04/2014
3	AutoantigensIBA 02/2012 - 06/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 11/2006
3	Myelin-Oligodendrocyte GlycoproteinIBA 11/2004 - 11/2002
2	Tyrosine Kinase InhibitorsIBA 05/2021 - 02/2013
2	Dasatinib (BMS 354825)FDA Link 05/2021 - 02/2013
2	LigandsIBA 01/2021 - 01/2012
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 12/2003
2	Triamcinolone (Aristocort)FDA Link 02/2013 - 12/2008
2	Green Fluorescent ProteinsIBA 02/2013 - 07/2012
2	Collagen Type I (Type I Collagen)IBA 02/2013 - 06/2004
2	Keratins (Keratin)IBA 07/2012 - 12/2003
2	Fluorescein (Funduscein)FDA LinkGeneric 04/2007 - 07/2005
1	Immunologic Factors (Immunomodulators)IBA 10/2021
1	SuspensionsIBA 05/2021
1	SolutionsIBA 05/2021
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 05/2021
1	LipopolysaccharidesIBA 01/2021
1	Volatile Fatty AcidsIBA 01/2021
1	EndotoxinsIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	durvalumabIBA 01/2020
1	pembrolizumabIBA 01/2020
1	atezolizumabIBA 01/2020
1	NivolumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	IpilimumabIBA 01/2020
1	TOPSIBA 01/2020
1	avelumabIBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	Adenosine Monophosphate (AMP)IBA 01/2016
1	CurcuminIBA 09/2015
1	Neuroprotective AgentsIBA 09/2015
1	2- ((aminocarbonyl)amino)- 5- (4- fluorophenyl)- 3- thiophenecarboxamideIBA 01/2015
1	FH535IBA 05/2014
1	CateninsIBA 05/2014
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2014
1	Interleukin-23 (Interleukin 23)IBA 08/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2013

Therapy/Procedure

10	Therapeutics 10/2021 - 11/2003
7	Lasers (Laser) 01/2015 - 03/2003
5	Transplantation 10/2021 - 02/2003
4	Intravitreal Injections 10/2021 - 07/2012
4	Traction 01/2016 - 07/2012
2	Transjugular Intrahepatic Portasystemic Shunt 01/2021 - 01/2019
2	Immunomodulation 01/2021 - 01/2018
2	Immunotherapy 01/2007 - 03/2003
2	Light Coagulation 01/2007 - 01/2005
1	Ligation 01/2021
1	Heterologous Transplantation (Xenotransplantation) 11/2018
1	Corneal Transplantation (Keratoplasty) 11/2018
1	Kidney Transplantation 01/2018